A critical discovery in cancer research is occurring with the use of nanobodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in many kinds of cancer, resulting uncontrolled body https://bookmarksurl.com/story7635382/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-hope-for-tumor-therapy